Segment disclosures

Company overview

POSITRON CORP

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

3 dimension combinations 54 retained observations 18 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Medical Devices

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=posc:MedicalDevicesMember
PeriodValueUnitFiledEvidence
2015-07-01 – 2015-09-30304000 USD20151123Open filing evidence
2015-01-01 – 2015-09-30978000 USD20151123Open filing evidence
2015-04-01 – 2015-06-30328000 USD20150814Open filing evidence
2015-01-01 – 2015-06-30674000 USD20150814Open filing evidence
2015-01-01 – 2015-03-31346000 USD20150515Open filing evidence
2014-01-01 – 2014-12-311449000 USD20150331Open filing evidence
2014-07-01 – 2014-09-30391000 USD20151123Open filing evidence
2014-01-01 – 2014-09-301202000 USD20151123Open filing evidence
2014-04-01 – 2014-06-30355000 USD20150814Open filing evidence
2014-01-01 – 2014-06-30811000 USD20150814Open filing evidence
2014-01-01 – 2014-03-31456000 USD20150515Open filing evidence
2013-01-01 – 2013-12-311630000 USD20150331Open filing evidence
2013-07-01 – 2013-09-30351000 USD20141215Open filing evidence
2013-01-01 – 2013-09-301154000 USD20141215Open filing evidence
2013-04-01 – 2013-06-30432000 USD20141215Open filing evidence
2013-01-01 – 2013-06-30803000 USD20141215Open filing evidence
2013-01-01 – 2013-03-31371000 USD20141215Open filing evidence
2012-01-01 – 2012-12-312789000 USD20140331Open filing evidence
2012-07-01 – 2012-09-30370000 USD20131118Open filing evidence
2012-01-01 – 2012-09-302423000 USD20131118Open filing evidence
2012-04-01 – 2012-06-301224000 USD20130814Open filing evidence
2012-01-01 – 2012-06-302053000 USD20130814Open filing evidence
2012-01-01 – 2012-03-31829000 USD20130517Open filing evidence
2011-01-01 – 2011-12-316663000 USD20130423Open filing evidence
2011-07-01 – 2011-09-30482000 USD20121121Open filing evidence
2011-01-01 – 2011-09-306374000 USD20121121Open filing evidence
2011-04-01 – 2011-06-303021000 USD20120821Open filing evidence
2011-01-01 – 2011-06-305892000 USD20120821Open filing evidence

Radiopharmaceuticals And Radioisotopes

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=posc:RadiopharmaceuticalsAndRadioisotopesMember
PeriodValueUnitFiledEvidence
2014-01-01 – 2014-03-310 USD20141215Open filing evidence
2013-01-01 – 2013-03-310 USD20141215Open filing evidence

Radiopharmaceuticals

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=posc:RadiopharmaceuticalsMember
PeriodValueUnitFiledEvidence
2015-07-01 – 2015-09-300 USD20151123Open filing evidence
2015-01-01 – 2015-09-300 USD20151123Open filing evidence
2015-04-01 – 2015-06-300 USD20150814Open filing evidence
2015-01-01 – 2015-06-300 USD20150814Open filing evidence
2015-01-01 – 2015-03-310 USD20150515Open filing evidence
2014-01-01 – 2014-12-3117000 USD20150331Open filing evidence
2014-07-01 – 2014-09-305000 USD20151123Open filing evidence
2014-01-01 – 2014-09-305000 USD20151123Open filing evidence
2014-04-01 – 2014-06-300 USD20150814Open filing evidence
2014-01-01 – 2014-06-300 USD20150814Open filing evidence
2014-01-01 – 2014-03-310 USD20150515Open filing evidence
2013-01-01 – 2013-12-310 USD20150331Open filing evidence
2013-07-01 – 2013-09-300 USD20141215Open filing evidence
2013-01-01 – 2013-09-300 USD20141215Open filing evidence
2013-04-01 – 2013-06-300 USD20141215Open filing evidence
2013-01-01 – 2013-06-300 USD20141215Open filing evidence
2013-01-01 – 2013-03-310 USD20130517Open filing evidence
2012-01-01 – 2012-12-3112000 USD20140331Open filing evidence
2012-07-01 – 2012-09-300 USD20131118Open filing evidence
2012-01-01 – 2012-09-300 USD20131118Open filing evidence
2012-04-01 – 2012-06-300 USD20130814Open filing evidence
2012-01-01 – 2012-06-300 USD20130814Open filing evidence
2012-01-01 – 2012-03-310 USD20130517Open filing evidence
2011-01-01 – 2011-12-310 USD20130423Open filing evidence